Ketalux - Ketamine Therapy EducationKetalux - Mental Wellness Authority
Condition overview

Chronic Migraine and ketamine research

Where ketamine fits in the treatment of refractory chronic migraine and other chronic headache disorders.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: May 18, 2026Evidence: Research summary

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

This page answers one question: what does published research currently say about ketamine and chronic migraine, and where does that evidence stop? It is a research overview, not treatment guidance.

Related on Ketalux

Overview

Chronic migraine (≥15 headache days/month) is disabling and often resistant to standard preventives. A subset of patients exhausts conventional options and requires more aggressive interventions.

Conventional treatment

First-line includes lifestyle modification, trigger management, and preventive medications (topiramate, beta-blockers, anti-CGRP monoclonal antibodies, onabotulinum toxin A for chronic migraine specifically).

Where ketamine fits

Inpatient lidocaine and subanesthetic ketamine infusions are used in specialized headache centers for refractory chronic migraine. Multi-day infusion protocols are most common in this setting.

What current evidence suggests

Retrospective and small prospective studies support short-term benefit; high-quality randomized trials are limited. Most evidence comes from headache specialty centers.

Limits of the evidence
This is a specialty intervention, typically delivered inpatient or in dedicated headache infusion centers — not a routine outpatient treatment.

Frequently asked questions

Is this the same as ketamine for depression?+

The medication is the same, but doses, protocols, and clinical setting differ. Headache protocols are typically multi-day continuous infusions.

Who's a candidate?+

Patients with refractory chronic migraine who have failed multiple preventive classes, evaluated by a headache specialist.

About the author

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.